CRP and COVID-19: The principal findings of this analysis of hospitalized patients with COVID-19 are (1) antecedent statin use was common in our cohort, as 36% of patients admitted to our institution were prescribed statins prior to their index admission; (2) patients receiving statins were older, with a higher burden of cardiovascular comorbidities, (3) patients receiving statins tended to present with lower levels of CRP, and (4) antecedent statin use was associated with significantly lower odds of patients experiencing the primary endpoint of in-hospital mortality in a propensity-matched analysis.